Background Pneumocystis pneumonia (PCP) is a disease affecting immunocompromised
patients. PCP among these patients is associated with significant morbidity and mortality …

P neumocystis jirovecii infection (PJP) is a common cause of pneumonia in patients with
cancer‐related immunosuppression. There are well‐defined patients who are at risk of PJP …

Chemotherapy-induced neutropaenia is a major risk factor for infection-related morbidity
and mortality and also a significant dose-limiting toxicity in cancer treatment. Patients …

Background Bacterial infections are a major cause of morbidity and mortality in patients who
are neutropenic following chemotherapy for malignancy. Trials have shown the efficacy of …

OBJECTIVE To assess the efficacy of prophylaxis for Pneumocystis pneumonia (PCP),
caused by Pneumocystis jirovecii (formerly Pneumocystis carinii), for immunocompromised …

After an increase in the number of reported cases of Pneumocystis jirovecii pneumonia in
England, we investigated data from 2000–2010 to verify the increase. We analyzed national …

The role of infection and chronic inflammation in plasma cell disorders (PCD) has been well-
described. Despite not being a diagnostic criterion, infection is a common complication of …

HIV-negative populations at risk for PJP can be identified. Conventional PCR increases
diagnostic sensitivity but may detect asymptomatic colonization. Quantitative PCR …

Chronic lymphocytic leukaemia (CLL) is the most common leukaemia with infections a
leading cause of morbidity and mortality. Recently there has been a paradigm shift from the …

Pneumocystis jiroveci pneumonia (PJP) is associated with high morbidity and mortality after
hematopoietic stem cell transplantation (HSCT). Little is known about PJP infections after …